Axsome Therapeutics, Inc.AXSMNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$11.22
Net Income/Share$-4.59
Operating CF/Share$-2.02
Free CF/Share$-2.02
Cash/Share$6.50
Book Value/Share$1.47
Tangible Book/Share$0.39
Equity/Share$1.47
Interest Debt/Share$4.52
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$9.29B
Enterprise Value$9.18B
P/E Ratio-40.15P/S Ratio16.55P/OCF Ratio-91.29
P/FCF Ratio-91.93
P/B Ratio125.01P/TB Ratio125.01
EV/Sales16.36EV/EBITDA-43.24
Graham Valuation
Graham Number--
Graham Net-Net$-2.22
Profitability
Earnings Yield-2.49%FCF Yield-1.09%ROE-357.21%ROIC-55.37%Return on Tangible Assets-37.32%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.09%
CapEx/Revenue0.02%
CapEx/Depreciation0.01
SBC/Revenue16.57%
SG&A/Revenue36.19%
R&D/Revenue33.76%
Liquidity & Solvency
Debt/Equity2.96Debt/Assets0.33Debt/Market Cap0.02
Net Debt/EBITDA0.50
Current Ratio1.57Interest Coverage-27.97xIncome Quality0.44Efficiency
Days Sales Outstanding128 days
Days Payables Outstanding433 days
Days Inventory190 days
Receivables Turnover2.86x
Payables Turnover0.84x
Inventory Turnover1.92x
Capital Structure
Tangible Assets$19.56M
Working Capital$205.05M
Invested Capital$285.87M
Intangibles/Assets8.09%